p53 Is Not Inactivated in B6C3F1 Mouse Vascular Tumors Arising Spontaneously or Associated with Long-Term Administration of the Thiazolidinedione Troglitazone
- 15 April 1999
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 156 (2) , 106-112
- https://doi.org/10.1006/taap.1999.8631
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in AngiosarcomasThe American Journal of Pathology, 1998
- Mutations ofp53 tumor-suppressor gene in angiosarcomaInternational Journal of Cancer, 1997
- p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotionCarcinogenesis: Integrative Cancer Research, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: Molecular dynamic and immunologic analysesProtein Journal, 1996
- Inhalation Oncogenicity Bioassay in Rats and Mice with Vinyl FluorideFundamental and Applied Toxicology, 1995
- Hepatocarcinogenesis in p53‐deficient miceMolecular Carcinogenesis, 1995
- p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workersCarcinogenesis: Integrative Cancer Research, 1994
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Spontaneous neoplasms in B6C3F1 miceToxicology Letters, 1992